Blog
873 Articles
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
Noninvasive Surgery and a New Drug to Stop Pancreatic Tumors
A clinical trial combines irreversible electroporation (IRE) and immunotherapy to see if the duo is effective against locally advanced pancreatic cancer.
Shedding Light on Chemo Brain
What is chemo fog or chemo brain? Are there techniques to counteract the side effects of chemotherapy on the brain?
Electrical Current to Help Relieve Jaundice
A clinical trial uses electrical current, in the form of radiofrequency ablation, to test the best technique for keeping a stent open to relieve jaundice.
Treating Tumors Before Pancreatic Cancer Surgery
Can neoadjuvant treatment such as chemoradiation make pancreatic cancer removal surgery more effective? That is the question asked by this clinical trial.
The ABCs of Genetic Testing
There are a number of different genetic mutations that can cause familial pancreatic cancer. This article explains some of the most common ones.
Testing an Experimental Combination of Drugs
A clinical trial for some cancers including pancreatic cancer tests the effectiveness of a checkpoint inhibitor and an antisense oligonucleotide inhibitor.
Overcoming Challenges to Vaccine Immunotherapy
Dr. Elizabeth Jaffee explains the challenges facing the scientists developing vaccine-based immunotherapy for pancreatic cancer.
World Pancreatic Cancer Coalition Members Demand Better on World Pancreatic Cancer Day
World Pancreatic Cancer Coalition members come together on World Pancreatic Cancer Day to demand better for patients, treatments, early detection, research.
Let’s Win and the Lustgarten Foundation Demand Better for World Pancreatic Cancer Day
Cindy Gavin of Let’s Win and Kerri Kaplan of the Lustgarten Foundation demand better for treatments and research on World Pancreatic Cancer Day.